Exploring the role of IGHV3-30 in the immune microenvironment and prognosis of uterine endometrial cancer.

Discov Oncol · 2026 · PMC13086979 · PMID 41806063

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

IGHV3-30 expression showed a trend of decrease with advancing tumor stage, with the most significant reduction observed between Stage I and Stage II (Fig. 5 C).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

III, etc.) did not reach statistical significance for all three scores.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.